These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25038124)

  • 61. Chronic axonal-demyelinating polyradicular neuropathy associated with mycosis fungoides: a case report.
    Cardinali P; Serrao M; Rossi P; De Dominicis L; Logullo F; De Santis F; Pierelli F
    Neurol Sci; 2005 Dec; 26(5):344-8. PubMed ID: 16388370
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Peripheral neuropathies associated with antibodies directed to intracellular neural antigens.
    Antoine JC
    Rev Neurol (Paris); 2014 Oct; 170(10):570-6. PubMed ID: 25194475
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The 301 to 314 amino acid residue of beta-tubulin is not a target epitope for serum IgM antibodies in chronic inflammatory demyelinating polyneuropathy.
    Tagawa Y; Yuki N; Hirata K
    J Neurol Sci; 1999 Feb; 163(1):44-6. PubMed ID: 10223409
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Extremely Painful Multifocal Acquired Predominant Axonal Sensorimotor Neuropathy of the Upper Limb.
    Lieba-Samal D; van Eijk JJJ; van Rosmalen MHJ; van Balken IMF; Verrips A; Mostert J; Pillen S; van Alfen N
    J Ultrasound Med; 2018 Jun; 37(6):1565-1574. PubMed ID: 29159899
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Arthritis associated with circulating immune complexes following administration of intravenous immunoglobulin therapy in a patient with chronic inflammatory demyelinating polyneuropathy.
    Lisak RP
    J Neurol Sci; 1996 Jan; 135(1):85-8. PubMed ID: 8926503
    [TBL] [Abstract][Full Text] [Related]  

  • 66. HCV-related central and peripheral nervous system demyelinating disorders.
    Mariotto S; Ferrari S; Monaco S
    Inflamm Allergy Drug Targets; 2014; 13(5):299-304. PubMed ID: 25198705
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Neuropathy with onion bulb formations and pure motor manifestations.
    Auer RN; Bell RB; Lee MA
    Can J Neurol Sci; 1989 May; 16(2):194-7. PubMed ID: 2543490
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Subcutaneous immunoglobulin therapy for the treatment of multifocal motor neuropathy: a case report.
    Dacci P; Riva N; Scarlato M; Andresen I; Schmidt D; Comi G; Fazio R
    Neurol Sci; 2010 Dec; 31(6):829-31. PubMed ID: 20574753
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The role of glycosphingolipids in neurological disorders. Mechanisms of immune action.
    Yu RK; Ariga T
    Ann N Y Acad Sci; 1998 Jun; 845():285-306. PubMed ID: 9668363
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Neurological picture. Spinal nerve root hypertrophy in chronic ataxic neuropathy with antiglycolipid IgM antibodies.
    Barnett MH; Barnett Y; Burke D; Willison H
    J Neurol Neurosurg Psychiatry; 2011 Jan; 82(1):97. PubMed ID: 20543185
    [No Abstract]   [Full Text] [Related]  

  • 71. Normalization of sonographical multifocal nerve enlargements in a MADSAM patient following a good clinical response to intravenous immunoglobulin.
    Tanaka K; Ota N; Harada Y; Wada I; Suenaga T
    Neuromuscul Disord; 2016 Sep; 26(9):619-23. PubMed ID: 27460345
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Marked and sustained improvement on nerve conduction study of anti-myelin-associated glycoprotein neuropathy following rituximab therapy.
    Al-Bustani N; Weiss MD
    Muscle Nerve; 2016 Mar; 53(3):489-90. PubMed ID: 26501896
    [No Abstract]   [Full Text] [Related]  

  • 73. Chronic relapsing axonal neuropathy responsive to intravenous immunoglobulin.
    Katirji B
    Neurology; 1997 Jun; 48(6):1690-4. PubMed ID: 9191788
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Monoclonal immunoglobulins and peripheral neuropathy: causative agent or coincidental finding?
    Owen RG
    Clin Lymphoma; 2004 Dec; 5(3):172-3. PubMed ID: 15636692
    [No Abstract]   [Full Text] [Related]  

  • 75. Serum CXCL13 reflects local B-cell mediated inflammatory demyelinating peripheral neuropathy.
    Kim YH; Jang SY; Shin YK; Jo YR; Yoon BA; Nam SH; Choi BO; Shin HY; Kim SW; Kim SH; Kim JK; Park HT
    Sci Rep; 2019 Nov; 9(1):16535. PubMed ID: 31712675
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Clinical and electrophysiological characteristics and therapeutic analysis of 9 patients with Lewis-Sumner syndrome].
    Sun A; Zhang Y; Liu X; Chen L; Sun Q; Zhang S; Fan D
    Zhonghua Yi Xue Za Zhi; 2016 Mar; 96(11):859-62. PubMed ID: 27045647
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Intravenous immunoglobulin in combination with ibrutinib for the treatment of IgM-type M protein associated peripheral neuropathy complicated with chronic lymphocytic leukemia].
    Sakata M; Saburi M; Kawano K; Takata H; Miyazaki Y; Uchida H; Kawano Y; Ohtsuka E
    Rinsho Ketsueki; 2021; 62(3):196-199. PubMed ID: 33828015
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Combination of high-dose intravenous immunoglobulins and itraconozole in treating chronic mycotic demyelinating optic neuritis.
    Campbell AW; Anyanwu EC; Vojdani A
    ScientificWorldJournal; 2003 Aug; 3():640-6. PubMed ID: 12920306
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A predominantly left upper limb sensory neuronopathy as a manifestation of a metastatic neuroendocrine malignancy.
    Lim A; Scriven A; Knezevic W; Texler M
    J Clin Neurosci; 2009 Jun; 16(6):838-9. PubMed ID: 19297166
    [TBL] [Abstract][Full Text] [Related]  

  • 80. High-dose intravenous methyl-prednisolone in chronic relapsing dysimmune polyneuropathy (CRDP).
    Castro-Gago M; Rodriguez-Núñez A
    Brain Dev; 1989; 11(5):347. PubMed ID: 2554742
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.